Investment House LLC Has $10.97 Million Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Investment House LLC grew its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.4% during the fourth quarter, HoldingsChannel.com reports. The firm owned 82,981 shares of the financial services provider’s stock after purchasing an additional 1,153 shares during the period. Investment House LLC’s holdings in iShares Biotechnology ETF were worth $10,971,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in IBB. Darwin Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF during the third quarter worth about $29,000. HHM Wealth Advisors LLC raised its position in shares of iShares Biotechnology ETF by 200.0% during the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 150 shares during the last quarter. VSM Wealth Advisory LLC bought a new position in shares of iShares Biotechnology ETF during the fourth quarter worth about $30,000. Bradley & Co. Private Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF during the fourth quarter worth about $32,000. Finally, Newbridge Financial Services Group Inc. bought a new position in shares of iShares Biotechnology ETF during the fourth quarter worth about $33,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

Shares of IBB opened at $134.09 on Wednesday. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57. The company has a market capitalization of $6.11 billion, a price-to-earnings ratio of 27.83 and a beta of 0.77. The business has a 50-day moving average of $136.26 and a 200-day moving average of $139.57.

iShares Biotechnology ETF Increases Dividend

The business also recently disclosed a dividend, which will be paid on Friday, March 21st. Stockholders of record on Tuesday, March 18th will be given a dividend of $0.1212 per share. This is an increase from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date of this dividend is Tuesday, March 18th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.